Kate Barnes (@barnes_johnson) header
Kate Barnes (@barnes_johnson) profile picture

GP practising Integrated Medicine: GPSI Hypermobility/PoTS/MCAS: Medicine = Art + Science: Educator: CBT/Hypnosis: Curiosity fuels Creativity

Bucks, Oxon and London
Joined May 2013
Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)Photo by Kate Barnes (@barnes_johnson)
📢 Published in the final form is the first Delphi consensus on #POTS and #Dysautonomia from the International POTS and Dysautonomia Collaborative! I am honored to serve as a Co-Chair, along with @KSivakoti89360, for this amazing collaborative group - all top POTS/dysautonomia experts. Uniting our colleagues from different specialties across the world, we had only one goal in mind: to improve the care of patients with POTS and Dysautonomia globally. 🌍 🫂 This work is a true labor of love, perseverance, resilience, professionalism and integrity. The paper has been already translated into several languages and shared by different academic, healthcare and government agencies. Thanks to our International POTS and Dysautonomia Collaborative members for investing their own time and effort into this important work! 🙏 @FudimMarat @ArturFedorowski @DH_Lau @DINETorg @HopkinsMECFSC @AANmember @BrainHealth_AAN @Jacobs_Med_UB @UofUHealth @ahsheadache @HRSonline @AASAutonomic amjmed.com/article/S0002-934…
6
40
4
122
4,735
📢 A new small study from Germany involving 18 patients with #POTS + hEDS and 20 healthy controls, utilizing MRI of the middle cerebral artery (MCA) and lower-body negative pressure chamber showed that patients with POTS/hEDS experience significant decrease in MCA flow when negative low-body pressure is applied, leading to increased heart rate and breathing rate and decreased end-tidal CO2 compared to healthy controls. ❓ What does that mean? As other researchers have shown in the past and, as is confirmed by this new study, there is altered physiology in patients with POTS that is associated with reduced blood flow to the brain - aka cerebral hypoperfusion. 💡 One hypothesis that can be generated from this study is that heart rate and breathing rate increase disproportionally in patients with POTS/hEDS to preserve adequate blood flow to the brain. 🧠 What else does it mean? Many things! 😃 1⃣ Heart rate elevation and increased respiration rate are INVOLUNTARY and occur in response to pathophysiologic factors. 2⃣ You cannot change your heart rate and respiration rate with positive thinking and the "right attitude": heart rate and respiration are controlled by the brainstem and not the cortex where thought process lives - i.e. POTS is not anxiety, depression, fear, FND, etc. 3⃣ Compensatory attempt by the body to preserve blood flow to the brain is vastly different from healthy blood flow to the brain ➡️ Expect brain changes on a cellular level, which in turn result in brain symptoms experienced by the patients. 4⃣ This MRI finding of reduced MCA blood flow in patients with POTS/hEDS may be an objective biomarker of disease process if replicated in large studies➡️ Anyone who says "we don't have biomarkers" is not following the literature. 5⃣ We don't know what the CAUSE of this altered physiology is as there are likely many of these CAUSES, which all lead down the same path of cerebral hypoperfusion and neuroinflammation. 6⃣ I am very interested in THERAPEUTIC TRIALS targeting cerebral hypoperfusion, neuroinflammation and neuroimmune etiology. This is where we SHOULD be investing our resources and our funding!!! ahajournals.org/doi/10.1161/…
12
116
9
403
11,010
Millions of dollars and international research efforts have gone into "proving" that disorders, like #POTS, #dysautonomia, #MECFS and #LongCOVID, are NOT CAUSED by deconditioning. David Systrom showed in his prepandemic studies that deconditionied people had high filling cardiac pressures while patients with disorders had low filling pressures. We now see confirmation from muscle studies by @RobWust and his team that not only cardiac physiology is different, but skeletal muscle composition is also different in patients vs. healthy deconditioned individuals. If we, as a medical community, only listened to millions of patients worldwide, the resources could've gone to therapeutics, which is ultimately what we need!!! nature.com/articles/s41467-0…
7
94
6
359
9,421
🫀🧠 When I see new studies and papers coming out on #POTS and #dysautonomia in scientific literature, I am so glad to see this progress! I remember a time when it was one or two papers per month, but now new papers are coming out almost daily! There is a huge need to advance the field: the more, the better! 🦠 Here is a new study (not yet peer-reviewed) that demonstrates impaired immune response in patients with post-COVID POTS, compared to people who recovered from COVID-19, in the form of increased T cell monocytes and proinflammatory cytokines. 📢 My take on this: This study should be replicated in people with POTS unrelated to COVID-19. pmc.ncbi.nlm.nih.gov/article…
4
27
3
150
4,544
🚨 Hot off the press: my new paper that moves this field forward 🚀 and changes the narrative on what #POTS, #MECFS and #LongCOVID are... Neuroimmune Disorders! 🧠 The brain and the autonomic nervous system are involved in the immune system regulation. 🧠 There is evidence of autoimmunity, immune dysregulation, cerebral hypoperfusion, neuroinflammation and other mechanisms in all three disorders. 🧠 #Neuroimmunology is a field that should embrace these disorders: #MultipleSclerosis, the staple of neuroimmunology, used to be called hysterical paralysis before CT and MRI were invented. We're at the same crossroads with these disorders. ❌ These disorders are not "mysterious", "anxiety", "deconditioning," "functional neurologic" etc. etc. ‼️ Classifying these disorders as neuroimmune and including them as part of neuroimmunology training is critical. 🛌 #PatientCare and lives of millions of people living with these disabling conditions are at stake! Thanks to my esteemed colleagues and co-authors, Dr. @TaylorDoherty8, immunologist from UC San Diego and Dr. Lawrence Steinman, neuroimmunologist from @StanfordMed, for their support! Read open-access paper here: 👇 dovepress.com/postural-ortho…
39
254
16
754
31,033
A few months ago I was asked by a journal to review a case report on #FND disguised as angioedema. I explained to the authors that angioedema is NEVER FND and that they should learn about allergies and mast cell activation syndrome (MCAS). The patient was so sick, they ended up in the ICU with angioedema and compromised airway. Today I received a notification from the journal that the paper was withdrawn. Good! I suggested that the authors rewrite the case as a complex presentation of MCAS, not FND. A disclaimer: I diagnose FND when the patient has FND and don't diagnose it when they don't. #POTS, #MCAS, #EDS, #LongCOVID are not FND. frontiersin.org/journals/neu…
6
12
2
134
4,407
Join Dysautonomia International on December 10th from 7:00-8:00PM Eastern for a free webinar with Dr. Amanda Miller to discuss her new research findings on using the Lumia device to track blood flow to the head in #dysautonomia. Register here: bit.ly/DysWebinar_Dec10
7
12
966
📢New Research Identifies Potential Biomarkers for Diagnosing Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD)! 🩸A recent study funded by The Ehlers-Danlos Society, and published in the American Journal of Medical Genetics, has identified potential blood-based biomarkers that could help diagnose hEDS and HSD. ❗This discovery is significant because diagnosing hEDS and HSD has been challenging due to the lack of established laboratory tests and molecular markers. What was the study, and what did it find❓ 🔬In this study, researchers examined blood samples from 466 adults, including 94 diagnosed with hEDS and 80 with HSD. 1. The study revealed the presence of a specific 52 kDa fragment of fibronectin in the blood of every individual with hEDS and HSD. This fragment was notably absent in healthy controls, individuals with other types of EDS, and those with various kinds of arthritis. 2. The consistent presence of the 52 kDa fibronectin fragment in individuals with hEDS and HSD suggests a possible common underlying pathophysiology, thus questioning the differentiation between these conditions. 3. Additionally, a fragment of collagen I was found in all individuals with hEDS and HSD, although this fragment was also present in other conditions. What could this study mean❓ The identification of these fragments could lead to the development of the first blood test for hEDS and HSD, providing a more reliable diagnostic tool for healthcare providers, and reducing the time to diagnosis, which currently averages around 12 years. What are the next steps❓ The study's findings are a significant step forward, but the authors emphasize that before this test is ready for diagnostic use, other investigators must confirm the results in additional cohorts of hEDS, HSD, and controls. The Ehlers-Danlos Society is sponsoring further confirmatory work. Currently, no diagnostic lab offers this test, but if validated, it could become an important tool in diagnosis and treatment trials and provide new insights into the underlying causes of hEDS and HSD. Of course, we will keep you up to date with all developments! Find an FAQ and further information, including a link to the research paper here: ehlers-danlos.com/new-resear… #hEDS #HypermobileEDS #HSD #hypermobility #hypermobilityspectrumdisorder #EhlersDanlossyndrome #medtwitter #meded
14
177
27
497
29,982
The #DysConf2024 lecture recordings are now available! You can register to view 25 recorded sessions from the leading dysautonomia experts for $25 at DysConf.org.
3
26
2
60
4,287
Kate Barnes retweeted
‘.. people are often struggling to function and ‘keep going’ most often in flux and dependant on many factors. This complex picture keeps people gauging what to do, when and how to do it whenever a headache presents, often learning from trial and error.’@NatMigraineCtr So true!
New paper from the CHESS (Chronic Headache Education and Self-management Study) team. Thank you to everyone involved. #clinicaltrials #headache #migraine @NatMigraineCtr @MigraineTrust
1
3
6
665
Therapeutic relationships are key ..suggestions cause beliefs which affect outcomes ..discover how to avoid words that hurt & find words that help. Learn skills to calm your patients & yourself #CPD #MedEd #MedTwitter @barnes_johnson @OneLongPlait @katejchartres @GNielsen_Physio
2
1
372
New research finds that COVID infects & significantly damages sensory and autonomic neurons before the virus infects the blood. Let's discuss... 🧵👇
9
131
11
323
16,073
Kate Barnes retweeted
He just wanted to help his mother. ❤️ 😂
792
12,924
983
107,056
11,580,477
Exciting new @BSMSMedSchool brain-body research. Role of #proprioception and #hypermobility in #emotions in #neurodivergence published by @royalsociety. News item here: tinyurl.com/mpw6ax2s. Full paper: tinyurl.com/yf32tpyh Thanks @LisaQuadt @DrSFink and @CritchleyHugo and to @sedsconnective for graphic.
21
79
14
200
34,504
Following our lively discussion on #stress and mind-body connection when it comes to #POTS or #LongCovid, here is my take on stress and some pointers to other physicians dealing with complex patients: #MedTwitter #NeuroTwitter ✔️ Stress is an important trigger for any chronic illness exacerbation. ✔️ Stress needs to be managed and reduced. ✔️ But living with a chronic illness that has no effective therapies is HIGHLY STRESSFUL ✔️ How do you reconcile this? 1⃣ Stop telling patients that their illness is CAUSED BY STRESS - most diseases are not CAUSED by stress. 2⃣ First, provide symptomatic control of physical symptoms - not a referral to a psychologist. 3⃣ LISTEN TO YOUR PATIENTS. Don't inject your own opinions and judgement. Most patients will tell you themselves if they are stressed or not. If they say they are not stressed, then don't push your narrative. They know better than their doctor if they're stressed or not. 4⃣ If there is comorbid anxiety, depression, PTSD, OCD and FND, then please by all means address that, but DO NOT use these comorbidities as an explanation of the chronic illness (e.g. your patient's 24-hr average heart rate of 100 bpm is not from anxiety, it's inappropriate sinus tachycardia so treat that!) 5⃣ If you're stuck with a complex patient, the best thing you can do for them is refer them out. It's OK to ask for help from your colleagues: none of us know everything. 6⃣ If all you have to offer to your patient with #POTS or #LongCovid is an antidepressant or psychotherapy, you're doing it wrong. Read this guidance statement to learn what to do and how to do it. onlinelibrary.wiley.com/doi/…
31
129
17
427
48,587
Hypermobile Ehlers-Danlos syndrome (hEDS) is a connective tissue disorder whose genetic cause has been difficult to identify. Researchers at the Norris Lab conducted a study looking for genetic links to hEDS by sequencing the DNA of families and individuals with hEDS. They discovered a specific change (variant) in the KLK15 gene that was associated with hEDS in two families. The KLK15 gene provides instructions for making a protein called kallikrein-15. To test what happens when this specific KLK15 genetic variant is present, the team created mice with an equivalent KLK15 variant. Six mice were studied and most had similar connective tissue problems to those seen in hEDS patients, such as weaker tendons and heart valve issues. It suggests that this KLK15 variant could play a role in causing hEDS in some people. A further analysis of 197 hEDS patients also showed that 65 (one third) had at least one kallikrein gene variant from within the whole family of kallikrein genes. This raises the possibility that other kallikrein gene variants may also be involved, but further work needs to be done to explore this. The findings highlight the importance of ongoing genetic research in understanding and diagnosing hEDS, which can lead to better health outcomes for patients. Further studies on kallikrein genes could reveal more about how they contribute to hEDS and related health issues, improving diagnosis and treatment. The KLK genes are not available on EDS genetic testing panels. It is too soon to recommend this because further studies are needed to replicate the findings, including further research in the HEDGE study looking at 1,000 people with hEDS and studies of the other KLK genes. hEDS remains a clinical diagnosis at this time.  The Norris Lab preprint can be read here:  researchsquare.com/article/r… Further information on genetics and inheritance can be found here: ehlers-danlos.com/genetics-a…
9
59
8
177
11,196
Today is a huge win for our field: #POTS, #MCAS and #MECFS are listed as pathophysiologic mechanisms of #LongCovid in the @theNASEM report on Long Covid definition. Many people and organizations worked tirelessly to make this happen, not only since the pandemic, but for decades before it, in order to legitimize these disorders, which have been largely neglected by the medical establishment. The silver lining of #Covid #pandemic is that it's finally acknowledged - through years of hard work by patients, physicians, researchers and numerous non-profit organizations - that these conditions are serious, complex, disabling and multi-systemic and require investment of resources to come up with effective therapies for many millions of people who have been disabled for decades. #MedTwitter @Dysautonomia @DINET @POTSActivist @DysSupport
The lack of a clear and consistent definition for #LongCOVID presents challenges for patients, clinicians, #PublicHealth practitioners, researchers, and policymakers. Read our new report on an evidence-based Long COVID definition: ow.ly/1fOT50SfxPc
28
315
28
944
66,942
EXCITING NEWS! Researchers at Medical University of South Carolina have identified kallikrein genetic variants in about 1/3 of individuals with hypermobile Ehlers-Danlos syndrome. A thread... 🧵👇
3
73
11
222
18,937
Kate Barnes retweeted
What should we do to influence large groups of people to change their behaviour? The most comprehensive synthesis of studies on behaviour change ever undertaken has been published & offers some clear steers: 1) For behaviour change at an individual level: - giving accurate information or trying to change beliefs is less effective - providing social support, tapping into individuals’ behavioural skills/habits & removing practical obstacles to behaviour is more effective 2) For behaviour change at a social/structural level: - interventions seeking to increase trustworthiness or targeting knowledge, general attitudes, beliefs, or mandates or other administrative/legal sanctions have negligible effect - access to resources that facilitate behaviour change & social support have the greatest impact asc.upenn.edu/news-events/ne…. Via @AnnenbergPenn Karen Lord
9
143
8
416
89,136